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Intracerebral Hemorrhage for the Palliative Care Provider:
What You Need to Know
B. Brent Simmons, M.D.1 and Susan M. Parks, M.D.2
Abstract
Intracerebral hemorrhage (ICH) makes up 10%–30% of all strokes. Palliative care providers are often asked to
get involved with ICH cases to aid with development of short-term and long-term goals. Prognosis can be cal-
culated using the ICH score (based on Glasgow Coma Score score, ICH volume, presence of intraventricular
hemorrhage, age, and location of origin) or the Essen score (based on age, NIH Stroke Scale [NIHSS], and level
of consciousness). Do-not-resuscitate (DNR) status is important to discuss with families. Expert consensus states
DNR is appropriate if the patient has two of the following: severe stroke, life-threatening brain damage, or sig-
nificant comorbidities. The process of withdrawing ventilatory support can differ greatly from that of a med-
ical intensive care unit (ICU) patient. Most ICH patients die within 24 hours following extubation. Symptoms
of dyspnea and pain warrant use of opioids before and after terminal extubation. In addition, treating death
rattle and postextubation stridor are important interventions. Family meetings are a vital intervention to help
explain prognosis, establish a plan of care, and to get all family members on the same page. Family meetings
can have a rapid effect, with 66% of families opting for withdrawal of life support to decide within 24 hours
of such a meeting.
Introduction
INTRACEREBRAL HEMORRHAGE (ICH), a type of hemorrhagicstroke, is a common cause of severe morbidity and mor-
tality, making up a significant proportion of all strokes. The
proportion of ICH is highest in patients of Asian or African
origin (30% of all strokes), with the incidence much smaller
in the white population (10%–15%).1 Long-term survival
varies greatly based on multiple prognostic factors. Overall,
the 2 year mortality rate is 60%–80%, with a 30-day mortal-
ity rate of 35%–52%.2,3 Palliative care providers are often
asked to get involved with ICH cases to aid with develop-
ment of short-term and long-term goals. This includes help-
ing the family establish goals of care, advance care planning,
end-of-life issues, and often explaining the prognosis and
utility of some interventions to families. The goal of this pa-
per is to better prepare the palliative care provider to confi-
dently treat the ICH patient and provide them with tools to
better estimate prognosis in these patients.
Pathophysiology
ICH should be differentiated from other stroke types. The
majority of strokes are ischemic in origin, arising from
atherothrombotic or embolic causes, and will not be discussed
further in this paper. There are two major types of intracra-
nial hemorrhage: intracerebral hemorrhage (ICH) and sub-
arachnoid hemorrhage (SAH). SAH are usually the result of
a ruptured aneurysm originating in the circle of Willis.1 SAH
is a distinct entity from ICH, with its own prognostic scores
and treatments and is beyond the scope of this paper.4–6
ICH arises from rupture of weakened arterial walls,
which can form small outpouchings called Charcot-
Bouchard microaneurysms. Chronic hypertension is usu-
ally the cause of this vessel weakening. Rapid increases in
blood pressure can predispose to rupture, even at lower
baseline levels of hypertension.1 A less common cause of
ICH is ruptured vascular malformations.1 Once hemor-
rhage has begun, the amount of bleeding is limited due to
the pressure of surrounding brain tissue.1 Larger volume
hematomas and edema can lead to enough pressure to dis-
place adjacent structures, leading to transtentorial hernia-
tion.1 This herniation is the cause of death for most pa-
tients who die during the first week after ICH.7 If patients
survive the first week, the causes of death are more var-
ied and include herniation, pneumonia, extension of he-
matoma, and cardiac causes.7
1Section of Geriatric Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania.
2Division of Geriatric Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
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Treatment Guidelines
The American Stroke Association (ASA) and American
Heart Association (AHA) jointly publish extensive guide-
lines for the treatment of ICH.3 The only subgroup that has
a clear recommendation for surgical evacuation are patients
with cerebellar hemorrhage greater than 3 cm with neuro-
logic deterioration, brainstem compression, or hydro-
cephalus.3 Other surgical approaches for the remainder of
ICH, such as urokinase infusion into the clot cavity and min-
imally invasive clot evacuation, have unknown and unclear
usefulness pending further clinical trials.3 Standard cran-
iotomy “might be considered” in patients with lobar clots
within 1 cm of the surface.3
Another section in the ASA/AHA guidelines that war-
rants mention is their statement on “Recommendation for
Withdrawal of Technological Support.” This section of the
guidelines recommends full aggressive care during the first
24 hours after onset of ICH and postponing new do-not-re-
suscitate (DNR) orders during that time. However, they state
that patients with a previous DNR order are exempt from
this recommendation.3
Prognosis
In order for the palliative care provider to aid families with
difficult decisions such as surgery, withdrawal of techno-
logical support, and other invasive measures such as artifi-
cial nutrition, it is important to have an estimated progno-
sis. Earlier prognostic formulas could predict mortality with
a high level of accuracy, however, they used complex alge-
braic equations that could pose some difficulty in bedside
calculation.8–11 Two newer models are easier to use and
achieve the same level of accuracy: the ICH score and the
Essen score.12–14
The first score specifically designed for rapid bedside cal-
culation and ease of use for those not trained in neurology
was Hemphill’s ICH score (Table 1).12 The ICH score was
designed to predict 30-day mortality following ICH and uses
five variables to calculate life expectancy: Glasgow Coma
Scale (GCS) score, ICH volume, intraventricular hemorrhage,
age, and infratentorial origin of ICH. Each of the variables
is assigned a score of 0, 1, or 2. The five variables are then
added up to equal the ICH score.
The original study included 152 patients. Of these, all pa-
tients with a score of 0 were alive at 30 days, and all patients
with a score of 5 had died by day 30. No patients in this
study scored a 6. For the remaining patients, scores of 1, 2,
3, and 4 had 30-day mortality rates of 13%, 26%, 72%, and
97%, respectively.12
The ICH score uses the ABC/2 method to calculate vol-
ume. If the computed tomography (CT) reading does not
have the volume listed, it can be calculated using this method
where A is the greatest hemorrhage diameter, B is the di-
ameter 90 degrees perpendicular to A, and C is the approx-
imate number of CT slices with hemorrhage. This product is
divided by 2, and then multiplied by the slice thickness in
millimeters.15 Simple to use ICH volume calculators are also
available online, such as the one found at http://sitemaker.
umich.edu/interact/ich_volume_calculator.
The Essen score is the latest prognostic tool to emerge, and
was published for the first time in 2006 (Table 1) This score
is unique in that it does not require a volume calculation and
only uses three variables: age, NIH Stroke Scale (NIHSS) to-
tal score, and the NIHSS level of consciousness. Age and con-
sciousness are assigned a score of 0 through 3; NIHSS is as-
signed a score of 0 through 4. The three variables are then
added up to equal the Essen score.12 An Essen score of
greater than 7 predicts 100-day mortality with 44% sensitiv-
ity and a 95% specificity. A score less than 3 predicts com-
plete recovery with 85% sensitivity and 86% specificity.
The sensitivity of the ICH score has been reported to be
as high as 79% for predicting mortality when the score is 3
or greater with specificity around 90%.14 This sensitivity is
considerably better than the Essen score, however, Essen has
superior specificity and is a good alternative to the ICH score
if radiologic data is missing or difficult to retrieve.
Practical Aspects of Care and End-of-Life 
Decision-Making
DNR orders
In 1996, DNR recommendations were published from a
consortium of 26 experts in acute stroke from New York and
Canada.16 DNR was defined by this consortium as with-
holding cardiopulmonary resuscitation (CPR). They con-
cluded that DNR orders are appropriate any time two of the
following clinical criteria are met:
TABLE 1. ICH AND ESSEN SCORES
FOR CALCULATING PROGNOSIS
ICH Essen
score Points score Points
Age 80 1 60 0
80 0 60–69 1
70–79 2
80 3
Level of GCS 3–4 2 Alert 0
consciousness 5–12 1 Drowsy 1
13–15 0 Stupor 2
Coma 3
Volume of ICH 30 1
30 0
Intraventricular Yes 1
hemorrhage No 0
Infratentorial Yes 1
origin No 0
NIHSS Score 0–5 0
6–10 1
11–15 2
16–20 3
Coma or 4
20
Total 0–6 0–10
Adapted from Hemphill JC, Bonovich DC, Besmertis L, Manley
GT, Johston SC: The ICH score: A simple, reliable grading scale for
intracerebral hemorrhage. Stroke 2001; 32:891–897; and Weimar C,
Benemann J, Diener HC: Development and validation of the Essen
intracerebral haemorrhage score. J Neuro Neurosurg Psychiatry
2006;77:601–605.
ICH, intracerebral hemorrhage; GCS, Glasgow Coma Score;
NIHSS, NIH Stroke Scale.
1. Severe stroke, defined as persistent/deteriorating neuro-
logical deficit, little or no activity on at least one side of
the body, and with either impaired consciousness, global
aphasia, or lack of response (GCS  9).
2. Life-threatening brain damage, associated with brainstem
compression, intraventricular extension, cerebellar le-
sions, infratentorial location involving multiple brainstem
levels, or midline shift.
3. Significant comorbidities, including pneumonia, pul-
monary embolism, sepsis, recent myocardial infarction,
cardiomyopathy, and life-threatening arrythmias.
DNR orders are often misinterpreted by staff to act as a
proxy for overall aggressiveness of care. Often it may be nec-
essary for the palliative care provider to educate family
members, nursing staff, and physicians to the fundamental
difference between having a DNR and decisions regarding
overall aggressiveness of care.
Withdrawal of ventilatory support
The process of withdrawing life support from an ICH pa-
tient can differ greatly from that of a medical ICU (MICU)
patient. MICU patients may be on many life-sustaining in-
terventions that can be withdrawn in a step-wise fashion and
are often patients with multiple organ failure and “physio-
logic futility.”17 By contrast, neurologic ICU patients usually
require only ventilatory support, are more often hemody-
namically stable, and have a lower mortality rate compared
to MICU patients.17,18 These differences can lead to longer
survival times and difficulties in family decision-making.
After a consensus is reached between the health care teams
and families for withdrawal of ventilatory support, terminal
extubation is performed. Terminal extubation in this setting
can lead to a wide range of survival time. A 1999 study of
life support withdrawal in neurologic ICU patients showed
25% mortality within one hour of extubation and 69% mor-
tality within 24 hours. The median duration of survival was
7.5 hours, with a range of 10 minutes to 11 days following
extubation.17 Interestingly, the GCS score at the time of ex-
tubation had no effect on the duration of survival.17 The ma-
jority (59%) of patients experienced agonal or labored breath-
ing following extubation.17 Given that many ICH patients
will be comatose, some of the palliative measures are done
to ease the process of death for family members.
Opioids have been shown to decrease the work of breath-
ing, control tachypnea, and decrease feelings of air-hunger
without causing increases in transcutaneous readings of
PCO2.19,20 Pain, although uncommon in ICH patients, may be
present and should be evaluated for if the patient is in dis-
tress. Liberal use of opioids to control dyspnea and pain is
recommended, starting with a bolus of 5 to 10 mg of mor-
phine if signs of distress are present, and then repeat doses
as often as every 10 minutes if needed. After comfort is at-
tained through this method, a continuous infusion of 50%
the loading dose per hour should be started and titrated as
appropriate.17 The mean dose of morphine during this study
was 6.3 mg/hr with a maximum dose of 20 mg/hr, and other
studies have shown the average dose of opioids as high as
18 mg/hr during the final 2 hours of life.17,21 Doses of opi-
oids exceeding what is necessary to achieve comfort are not
recommended.22
Postextubation stridor and “death rattle” are common and
can be quite distressing to family members. The death rattle
results from excessive bronchopulmonary secretion. One rec-
ommendation to control this phenomenon includes a two-
phase process. The first phase, starting 6 hours prior to ex-
tubation involves stopping enteral feedings and reducing
parenteral fluids. Also at this time, furosemide can be given
in cases of fluid overload, and 100 mg methylprednisolone
IV can be given to help prevent postextubation stridor.22 The
second phase, carried out 30 minutes prior to extubation, in-
volves administration of 20 mg butylscopolamine or 0.4 mg
hyoscine hydrobromine to prevent death rattle.22
Palliative sedation is often not necessary in terminal ICH
patients due to the extensive neurologic damage. However,
if it is required for relief of intractable symptoms distressing
to the patient and family despite opioid administration, se-
dation may be warranted.22 Propofol or benzodiazepines
such as midazolam or lorazepam can be used to this effect.
Finally, many facilities have their own weaning protocols,
and we encourage you to inquire about such a protocol at
your institution.
A common barrier to liberal narcotic use among families
and health care providers is concern over hastening death
through respiratory depression. Multiple studies have
shown this not to be the case. A small, recent study showed
opioid treatment of dyspnea to significantly decrease tachyp-
nea, with average respiration rate dropping from 41.8 per
minute prior to opioid administration to 26.5 per minute 60
minutes following dosing. Despite this impressive decrease
in respiratory rate, SaO2, PaCO2, and pulse rate showed no
significant change from baseline.20 The authors go on to state
that since there was no increase in hypercapnia, opioid ad-
ministration did not lead to respiratory depression despite
decreased respiratory rate.20 Additionally, a 2004 study in-
vestigated narcotic use after withdrawal of mechanical ven-
tilation in ICU patients. This study showed a steep escala-
tion of narcotic use during the last 2 hours of life, however,
no statistical association was observed between opioid use
and time of death.21 There is a physiologic basis to the ob-
servation that opioids do not cause respiratory depression,
and can actually lead to a small prolongation of life. It has
been proposed that opioids decrease the demand for oxygen
and attenuate the cardiopulmonary response to increased
work of breathing, leading to a higher tolerance to decreased
levels of oxygen delivery.19 These data should reassure
physicians and families that they should not withhold com-
fort measures following terminal extubation.
Family meetings
ICH happens very suddenly and usually catches families
off guard. The family meeting is a vital intervention to help
explain prognosis, to formulate a plan of care most in-line
with the patient’s wishes, and to get all family members on
the same page. The family meeting can have a rapid effect,
with one study showing the interval between discussing
withdrawal of life support to actual extubation to be less than
24 hours in 66% of patients.17 This same study surveyed the
families of ICU patients 1 year after undergoing terminal ex-
tubation. The most important factors families used in their
decision to withdraw ventilatory support included quality
of life, overall prognosis, and current level of suffering. Sev-
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enty-five percent of respondents felt that the decision to
withdraw life support should be made by the family and
physicians together.17 The family meeting facilitates shared
decision making between health care providers and families.
Summary
ICH is a common and often fatal condition. Because of
this, palliative care providers are often consulted to aid the
patient, family, and health care providers in difficult end-of-
life decision-making. In order to appropriately guide these
discussions, an understanding of prognosis is vital. The score
calculations outlined in this article are a valuable tool; how-
ever, their limitations should be recognized. The family
meeting is a key intervention for the palliative care provider
to use in conjunction with the neurology and neurosurgery
primary teams. If a decision is made for terminal extubation,
the focus should be on comfort care and use of opioids for
respiratory distress or pain and consideration can be given
to anticipatory measures to prevent death rattle and postex-
tubation stridor. Discussing DNR orders with the family is
important for the palliative care provider. It should be made
clear that DNR orders do not equal withdrawal of aggres-
sive treatment. The palliative care provider can play a cen-
tral role in providing care for ICU patients with ICH and
their families.
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